Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-613-81.
Published January 31, 2024 · Recall initiated: January 18, 2024
Summary
FDA records drug Class II recall D-0269-2024, published January 31, 2024 and initiated January 18, 2024. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Completed; Reported quantity: 6552 bottles; Lot: Lot #: DNE0788A Exp. 07/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
What to do
Voluntary: Firm initiated · Letter
Get an email if NIACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NIACIN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide in the USA
- UPC
- 0347335613810
- Lot
- Lot #: DNE0788A Exp. 07/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured byJune 17, 2026
- FDANiacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company,June 10, 2026
- FDANIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers UrbanNovember 26, 2025
- FDANiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: LannettOctober 29, 2025
- FDAMesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily,January 31, 2024
- FDANiacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun PharmaceuticalJanuary 31, 2024
Questions about this recall
Was Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-613-81. recalled?
Yes. FDA published recall D-0269-2024 on January 31, 2024. Reported hazard: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NIACIN. UPC: 0347335613810.